A federal appellate court has rejected Bidi Vapor’s request to stay the latest denial by the US Food and Drug Administration (FDA) of its premarket tobacco product application (PMTA).
The decision on 15th February from the US Court of Appeals for the Eleventh Circuit comes about a month after the FDA issued a marketing denial order (MDO) to Bidi that means the company can no longer sell its products in the US.